Related Experiment Video
Updated: Jul 14, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
19.5K
A Review of Pharmacovigilance
J E Campbell1, M Gossell-Williams2, M G Lee3
1Pharmacology Section, Department of Basic Medical Sciences, Faculty of Medical Sciences, The University of the West Indies, Kingston 7, Jamaica. jacqueline.campbell02@uwimona.edu.jm.
The West Indian Medical Journal
|April 14, 2015
Summary
Improving pharmacovigilance knowledge can help reduce underreporting of adverse drug reactions (ADRs). This is crucial for safe medication use, especially in developing nations where ADRs pose a significant challenge.
Area of Science:
- Pharmacovigilance
- Drug Safety
- Public Health
Background:
- Spontaneous reporting of adverse drug reactions (ADRs) is vital for pharmacovigilance.
- Significant underreporting of ADRs hinders effective drug safety monitoring.
- ADRs represent a major public health concern, particularly in developing countries.
Purpose of the Study:
- To highlight the importance of pharmacovigilance in ensuring drug safety.
- To address the issue of underreporting of adverse drug reactions.
- To explore the potential of pharmacovigilance knowledge in improving ADR reporting rates.
Main Methods:
- Literature review on pharmacovigilance and ADR reporting.
- Analysis of the impact of ADRs in developing countries.
- Assessment of knowledge gaps in pharmacovigilance.
Main Results:
- Pharmacovigilance knowledge is essential for the safe and appropriate use of medications.
- Underreporting of ADRs is a widespread issue with serious consequences.
- Increased knowledge of pharmacovigilance can empower interventions to improve reporting.
Conclusions:
- Pharmacovigilance knowledge is fundamental for enhancing drug safety.
- Interventions based on pharmacovigilance education can improve ADR reporting rates.
- Addressing ADRs through improved reporting is critical for public health, especially in resource-limited settings.
Related Concept Videos
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:10Pharmacokinetics: Overview
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV) administration...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).